Correlation between extraintestinal manifestations and clinical parameters with the histologic activity index in patients with inflammatory bowel diseases

Miloš Štulić; Djordje Ćulafić; Dragana Mijač; Goran Janković; Ivana Jovičić; Miodrag Krstić; Tomica Milosavljević

doi:10.2298/1423

Miloš Štulić Clinic of Gastroenterology, Clinical Center of Serbia, Belgrade, Serbia
Djordje Ćulafić Clinic of Gastroenterology, Clinical Center of Serbia, Belgrade, Serbia; Faculty of Medicine, University of Belgrade, Serbia
Dragana Mijač Clinic of Gastroenterology, Clinical Center of Serbia, Belgrade, Serbia; Faculty of Medicine, University of Belgrade, Serbia
Goran Janković Clinic of Gastroenterology, Clinical Center of Serbia, Belgrade, Serbia; Faculty of Medicine, University of Belgrade, Serbia
Ivana Jovičić Clinic of Gastroenterology, Clinical Center of Serbia, Belgrade, Serbia;
Miodrag Krstić Clinic of Gastroenterology, Clinical Center of Serbia, Belgrade, Serbia; Faculty of Medicine, University of Belgrade, Serbia
Tomica Milosavljević Clinic of Gastroenterology, Clinical Center of Serbia, Belgrade, Serbia; Faculty of Medicine, University of Belgrade, Serbia

DOI: https://doi.org/10.2298/1423

Keywords: crohn disease, colitis, ulcerative, severity of illness index, signs and symptoms, histological techniques,

Abstract

Bacground/Aim. Crohn's disease (CD) and ulcerative colitis (UC) are chronic, idiopathic, inflammatory diseases of the digestive tract. The aim of this study was to determine a possible correlation between the clinical parameters of the disease activity degree and the presence of extraintestinal manifestations with disease activity histopathological degree, in patients presented with CD and UC. Methods. This cross-sectional study included 134 patients (67 with CD and UC, respectively) treated at the Clinic of Gastroenterology, Clinical Center of Serbia, Belgrade. After clinical, laboratory, endoscopic, histopathologic and radiologic diagnostics, the patients were divided into two groups according to their histopathological activity. The group I comprised 79 patients whose values of five-grade histopathological activity were less than 5 (45 with CD and 34 with UC), while the group II consisted of 55 patients with the values higher than 5 (22 with CD and 33 with UC). The CD activity index (CDAI) and Truelove and Witts' scale of UC were used for clinical evaluation of the disease activity. Results. CD extraintestinal manifestations were present in 28.9% and 63.6% of the patients in the groups I and II, respectively (p < 0.05). Comparison of the mean CDAI values found a significant difference between these two patients groups (the group I: 190.0 ± 83.0, the group II: 263.4 ± 97.6; p < 0.05). No correlation of extraintestinal manifestations of the disease, Truelove and Witts' scale and histological activity was found in UC patients (p > 0.05). Conclusion. In the patients presented with CD, the extraintestinal manifestations with higher CDAI suggested a higher degree of histopathological activity. On the contrary, in the UC patients, Truelove and Witts' scale and extraintestinal manifestations were not valid predictors of the disease histopathological activity.

Author Biography

Miodrag Krstić, Clinic of Gastroenterology, Clinical Center of Serbia, Belgrade, Serbia; Faculty of Medicine, University of Belgrade, Serbia

Redovni profesor (Interna medicina), Medicinskog fakulteta Univerziteta u Beogradu. Zaposlen na Klinici za gastroenterologiju, KCS-a.

References

Steinhardt HJ, Loeschke K, Kasper H, Holtermüller KH, Schäfer H. European Cooperative Crohn’s Disease Study (ECCDS): clinical features and natural history. Digestion 1985; 31(2−3): 97−108.

Griffel LH, Das KM. Ulcerative colitis: pathogenesis, diagno-sis, and current treatment. J Assoc Acad Min Phys 1996; 7(3): 63–9.

Van Assche G, Dignass A, Panes J, Beaugerie L, Karagiannis J, Allez M, et al. The second European evidence-based consensus on the diagnosis and management of Crohn’s disease: Definitions and diagnosis. J Crohns Colitis 2010; 4(1): 7−27.

Popović O, Vukčević V. Inflammatory bowel diseases: Crohn’s Disease and ulcerative colitis. In: Manojlović D, editor. Internal medicine I. Belgrade: Zavod za udžbenike i nastavna sredstva; 2006. p. 687–700. (Serbian)

Best WR, Becktel JM, Singleton JW. Rederived values of the eight coefficients of the Crohn’s Disease Activity Index (CDAI). Gastroenterology 1979; 77(4 Pt 2): 843−6.

Truelove SC, Witts LJ. Cortisone in ulcerative colitis. Final re-port on a therapeutic trial. Br Med J 1955; 2(4947): 1041–8.

Geboes K, Riddell R, Ost A, Persson T, Lofberg R. A Reproducible grading scale for histological assessment of inflammation in ulcerative colitis. Gut 2000; 47(3): 404–9.

Calkins BM, Lilienfeld AM, Garland CF, Mendeloff AI. Trends in the incidence rates of ulcerative colitis and Crohn’s disease. Dig Dis Sci 1984; 29(10): 913−20.

Herrinton LJ, Liu L, Lewis JD, Griffin PM, Allison J. Incidence and Prevalence of Inflammatory Bowel Disease in a Northern California Managed Care Organization, 1996–2002. Am J Gastroenterol 2008; 103(8): 1998–2006.

Polito JM 2nd, Childs B, Mellits ED, Tokayer AZ, Harris ML, Bayless TM. Crohn's disease: Influence of age at diagnosis on site and clinical type of disease. Gastroenterol 1996; 111(3): 580–6.

Satsangi J, Morecroft J, Shah NB, Nimmo E. Genetics of inflam-matory bowel disease: scientific and clinical implications. Best Pract Res Clin Gastroenterol 2003; 17(1): 3–18.

Hendrickson BA, Gokhale R, Cho JH. Clinical aspects and pa-thophysiology of inflammatory bowel disease. Clin Microbiol Rev 2002; 15(1): 79–94.

Hugot JP, Chamaillard M, Zouali H, Lesage S, Cezard JP, Belaiche J, et al. Association of NOD2 leucine rich repeat variants with susceptibility to Crohn’s disease. Nature 2001; 411(6837): 599–603.

Lakatos PL, Fischer S, Lakatos L, Gal I, Papp J. Current con-cept on the pathogenesis of inflammatory bowel disease-crosstalk between genetic and microbial factors: Pathogenic bacteria and altered bacterial sensing or changes in mucosal integrity take “toll”? World J Gastroenterol 2006; 12(12): 1829–41.

Mylonaki M, Langmead L, Pantes A, Johnson F, Rampton DS. Enteric infection in relapse of inflammatory bowel disease: importance of microbiological examination of stool. Eur J Gastroenterol Hepatol 2004; 16(8): 775–8.

Meyer AM, Ramzan NN, Loftus EV Jr, Heigh RI, Leighton JA. The diagnostic yield of stool pathogen studies during relapses of inflammatory bowel disease. J Clin Gastroenterol 2004; 38(9): 772–5.

Agrawal D, Rukkannagari S, Kethu S. Pathogenesis and clinical approach to extraintestinal manifestations of inflammatory bowel disease. Minerva Gastroenterol Dietol 2007; 53(3): 233–48.

Larsen S, Bendtzen K, Nielsen OH. Extraintestinal manifesta-tions of inflammatory bowel disease: Epidemiology, diagno-sis, and management. Ann Med 2010; 42(2): 97–114.

Aghazadeh R, Zali MR, Bahari A, Amin K, Ghahghaie F, Firouzi F. Inflammatory bowel disease in Iran: a review of 457 cases. J Gastroenterol Hepatol 2005; 20(11): 1691–5.

Yüksel I, Başar O, Ataseven H, Ertuğrul I, Arhan M, Ibiş M, et al. Mucocutaneous manifestations in inflammatory bowel dis-ease. Inflamm Bowel Dis 2009; 15(4): 546–50.

Vavricka SR, Brun L, Ballabeni P, Pittet V, Vavricka BM, Zeitz J, et al. Frequency and risk factors for extraintestinal manifestations in the Swiss inflammatory bowel disease cohort. Am J Gastroenterol 2011; 106(1): 110–9.

Mendoza JL, Lana R, Taxonera C, Alba C, Izquierdo S, Díaz-Rubio M. Extraintestinal manifestations in inflammatory bo-wel disease: differences between Crohn’s disease and ulcera-tive colitis. Med Clin (Barc) 2005; 125(8): 297–300. (Spanish)

Meier C, Plevy S. Therapy insight: how the gut talks to the joints-inflammatory bowel disease and the spondyloarthropa-thies. Nat Clin Pract Rheumatol 2007; 3(11): 667–74.

Triantafillidis JK, Merikas E, Malgarinos G, Panteris V, Peros G. Acute idiopathic pancreatitis preceding diagnosis of Crohn’s disease. Description of three cases. Rev Med Chir Soc Med Nat Iasi 2009; 113(1): 97–102.

Rogler G, Schölmerich J. Extraintestinal manifestations of in-flammatory bowel disease. Med Klin (Munich) 2004; 99(3): 123–30. (German)